speb/financial-data huggingface dataset:
DuPont ROE decomposition for DIOD (annual period ending 2024-12-31)
ROE: 2.764185739015458%
Net margin: 3.877753371163585%
Asset turnover: 0.5515929944425045
Equity multiplier (leverage): 1.292314735074854
EBIT margin: 3.9203124046616633%
Interest burden factor: 1.2194941634241245
Tax burden factor: 0.811110047541559
ROE archetype: Low Return
DuPont ROE decomposition for DIOD (annual period ending 2025-12-31)
ROE: 3.6334926389862154%
Net margin: 4.667111539040249%
Asset turnover: 0.6131386831116538
Equity multiplier (leverage): 1.2697475623503556
EBIT margin: 2.457908618536334%
Interest burden factor: 2.304793016361041
Tax burden factor: 0.8238545004109149
ROE archetype: Low Return
DuPont ROE decomposition for DIVI.L (quarterly period ending 2024-11-30)
Equity multiplier (leverage): 1.001620403581767
ROE archetype: Standard Business
DuPont ROE decomposition for DIVI.L (quarterly period ending 2025-05-31)
Equity multiplier (leverage): 1.0056172848321805
ROE archetype: Standard Business
DuPont ROE decomposition for DIVI.L (quarterly period ending 2025-11-30)
Equity multiplier (leverage): 1.190561730840743
ROE archetype: Standard Business
DuPont ROE decomposition for DKL.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 6.240530049524831
ROE archetype: Standard Business
DuPont ROE decomposition for DKL.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 6.384909709495999
ROE archetype: Standard Business
DuPont ROE decomposition for DKS (quarterly period ending 2025-01-31)
ROE: 9.379150689248918%
Net margin: 7.7040842664554505%
Asset turnover: 0.3722882608478649
Equity multiplier (leverage): 3.270115912882739
EBIT margin: 10.213504093460916%
Interest burden factor: 0.9989815881190309
Tax burden factor: 0.7550727081880722
ROE archetype: Standard Business
DuPont ROE decomposition for DKS (quarterly period ending 2025-04-30)
ROE: 8.456325718028406%
Net margin: 8.324878404952694%
Asset turnover: 0.3038946118358844
Equity multiplier (leverage): 3.3425722539930995
EBIT margin: 11.955798967895001%
Interest burden factor: 0.9161234910079619
Tax burden factor: 0.7600554465923928
ROE archetype: Standard Business
DuPont ROE decomposition for DKS (quarterly period ending 2025-07-31)
ROE: 11.90489864970316%
Net margin: 10.459066707325366%
Asset turnover: 0.3452359825655931
Equity multiplier (leverage): 3.2969830573017784
EBIT margin: 12.958178212348107%
Interest burden factor: 1.0788957431724635
Tax burden factor: 0.748116967690304
ROE archetype: Standard Business
DuPont ROE decomposition for DKS (quarterly period ending 2025-10-31)
ROE: 1.6948245454814839%
Net margin: 1.8046088402607339%
Asset turnover: 0.2964502382631622
Equity multiplier (leverage): 3.168034196643318
EBIT margin: 6.292569197026805%
Interest burden factor: 0.3981049340349272
Tax burden factor: 0.7203731550566533
ROE archetype: Low Return
DuPont ROE decomposition for DKS (quarterly period ending 2026-01-31)
ROE: 2.3206312539413814%
Net margin: 2.0612895423007895%
Asset turnover: 0.3574228771103719
Equity multiplier (leverage): 3.1498131417812445
EBIT margin: 3.449167000478955%
Interest burden factor: 0.8383260301657299
Tax burden factor: 0.7128724420645677
ROE archetype: Low Return
DuPont ROE decomposition for DKS (quarterly period ending 2026-04-30)
ROE: 5.73961869874315%
Net margin: 6.192695368228972%
Asset turnover: 0.2930677043186638
Equity multiplier (leverage): 3.1625351612707555
EBIT margin: 10.055834984346996%
Interest burden factor: 0.8593217466986564
Tax burden factor: 0.7166478068455548
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4643535878425178
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2025-03-31)
ROE: 5.933102106830156%
Net margin: 7.418692150914984%
Asset turnover: 0.5260358482829786
Equity multiplier (leverage): 1.5203344315137355
EBIT margin: 8.314338784146916%
Interest burden factor: 1.205323540222557
Tax burden factor: 0.7402799629738577
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2025-06-30)
Net margin: 6.961128804529109%
EBIT margin: 7.883217348789816%
Interest burden factor: 1.1872156209245037
Tax burden factor: 0.7437835462698227
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2025-09-30)
ROE: 5.373048248311661%
Net margin: 6.738324112179013%
Asset turnover: 0.4896466086448231
Equity multiplier (leverage): 1.6284937379436386
EBIT margin: 8.279071595224737%
Interest burden factor: 1.102340259715269
Tax burden factor: 0.7383369264473558
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2025-12-31)
Net margin: 6.754282533336705%
EBIT margin: 8.28853014852863%
Interest burden factor: 1.101565767421414
Tax burden factor: 0.739760725638162
ROE archetype: Standard Business
DuPont ROE decomposition for DLINKINDIA.NS (quarterly period ending 2026-03-31)
ROE: 5.460244261283638%
Net margin: 6.2228809046185365%
Asset turnover: 0.5468182707166
Equity multiplier (leverage): 1.6046398174368386
EBIT margin: 7.485022450266962%
Interest burden factor: 1.1090897594551383
Tax burden factor: 0.749603639996525
ROE archetype: Standard Business
DuPont ROE decomposition for DLTR (annual period ending 2023-01-31)
ROE: 18.45854996286351%
Net margin: 10.481783084060604%
Asset turnover: 0.6694219901746583
Equity multiplier (leverage): 2.6306461749414387
EBIT margin: 13.621646173312138%
Interest burden factor: 0.9392178345162673
Tax burden factor: 0.81929299589187
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DLTR (annual period ending 2024-01-31)
ROE: -12.429814623457789%
Net margin: -5.949550387042566%
Asset turnover: 0.7450716607171399
Equity multiplier (leverage): 2.8040287339865295
EBIT margin: 10.574396195720185%
Interest burden factor: 0.936545505776275
Tax burden factor: -0.600758168361514
ROE archetype: Low Return
DuPont ROE decomposition for DLTR (annual period ending 2025-01-31)
ROE: -53.675213675213676%
Net margin: -17.23753448815314%
Asset turnover: 0.8644986783057724
Equity multiplier (leverage): 3.6019219697976173
EBIT margin: 8.316978126688852%
Interest burden factor: 0.9463748290013679
Tax burden factor: -2.1900115640358484
ROE archetype: Low Return
DuPont ROE decomposition for DLTR (annual period ending 2026-01-31)
ROE: 33.17253598541184%
Net margin: 6.606806169443328%
Asset turnover: 1.2090737522656352
Equity multiplier (leverage): 4.152735925921136
EBIT margin: 8.515954213416583%
Interest burden factor: 0.9857237916641461
Tax burden factor: 0.7870512427124885
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.8228286522737143
ROE archetype: Standard Business
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2025-03-31)
ROE: 2.904364456540727%
Net margin: 5.168365603007932%
Asset turnover: 0.3220170830381957
Equity multiplier (leverage): 1.7450945978523151
EBIT margin: 8.854328054970786%
Interest burden factor: 0.8421574817353659
Tax burden factor: 0.6931134197279639
ROE archetype: Low Return
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2025-06-30)
Net margin: 6.1043946572378305%
EBIT margin: 9.981903750622822%
Interest burden factor: 0.8697609866496337
Tax burden factor: 0.7031197584703119
ROE archetype: Standard Business
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2025-09-30)
ROE: 2.454543902480665%
Net margin: 4.5629970991310085%
Asset turnover: 0.33622854039039274
Equity multiplier (leverage): 1.5998749423795948
EBIT margin: 7.844406781812757%
Interest burden factor: 0.8379288719857582
Tax burden factor: 0.6941973177532864
ROE archetype: Low Return
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2025-12-31)
Net margin: 4.088854892613456%
EBIT margin: 7.261467445988565%
Interest burden factor: 0.8066836450602917
Tax burden factor: 0.6980299412716554
ROE archetype: Standard Business
DuPont ROE decomposition for DMCC.NS (quarterly period ending 2026-03-31)
ROE: 3.0841245012640153%
Net margin: 4.308751142755493%
Asset turnover: 0.398739231911924
Equity multiplier (leverage): 1.795111883676757
EBIT margin: 7.8907548265938905%
Interest burden factor: 0.7712952658162828
Tax burden factor: 0.7079656658712101
ROE archetype: Low Return
DuPont ROE decomposition for DNB.OL (quarterly period ending 2024-12-31)
ROE: 4.473660990029119%
Net margin: 59.05786972323175%
Asset turnover: 0.0059383668246117665
Equity multiplier (leverage): 12.756110473837468
Tax burden factor: 0.9505774711264435
ROE archetype: Low Return
DuPont ROE decomposition for DNB.OL (quarterly period ending 2025-03-31)
ROE: 3.909017521021538%
Net margin: 49.56593255962716%
Asset turnover: 0.0059366137409146225
Equity multiplier (leverage): 13.284510072524274
Tax burden factor: 0.7968267959453503
ROE archetype: Low Return
DuPont ROE decomposition for DNB.OL (quarterly period ending 2025-06-30)
ROE: 3.7444098970611197%
Net margin: 47.286962031044936%
Asset turnover: 0.005733263013290581
Equity multiplier (leverage): 13.811476394799698
Tax burden factor: 0.7981819570697426
ROE archetype: Low Return
DuPont ROE decomposition for DNB.OL (quarterly period ending 2025-12-31)
ROE: 3.924895641445981%
Net margin: 50.19885872384575%
Asset turnover: 0.006259860525154994
Equity multiplier (leverage): 12.490206351084153
Tax burden factor: 0.8700734302412708
ROE archetype: Low Return
DuPont ROE decomposition for DNB.OL (quarterly period ending 2026-03-31)
ROE: 3.3604016770631726%
Net margin: 45.803936130709246%
Asset turnover: 0.005811125194149635
Equity multiplier (leverage): 12.624906209862434
Tax burden factor: 0.7763354574777751
ROE archetype: Low Return
DuPont ROE decomposition for DNL.AX (annual period ending 2022-09-30)
ROE: 16.118415822694246%
Net margin: 16.053077446835463%
Asset turnover: 0.5813212809632078
Equity multiplier (leverage): 1.7272206941507544
EBIT margin: 20.25873671876237%
Interest burden factor: 1.0620603407847429
Tax burden factor: 0.7460994995584339
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DNL.AX (annual period ending 2023-09-30)
ROE: 8.751309677533925%
Net margin: 10.349479753830233%
Asset turnover: 0.5021696661121747
Equity multiplier (leverage): 1.6838525448968873
EBIT margin: 6.601489585835998%
Interest burden factor: 0.8885778275475924
Tax burden factor: 1.7643352236925016
ROE archetype: Standard Business
DuPont ROE decomposition for DNL.AX (annual period ending 2024-09-30)
ROE: -5.747596443132238%
Net margin: -5.88993085156768%
Asset turnover: 0.5800510837681447
Equity multiplier (leverage): 1.682324728343872
EBIT margin: 6.590887562754571%
Interest burden factor: -1.9767174475423972
ROE archetype: Low Return
DuPont ROE decomposition for DNL.AX (annual period ending 2025-09-30)
ROE: -1.0954938724051626%
Net margin: -1.4042748173903667%
Asset turnover: 0.4460933019272875
Equity multiplier (leverage): 1.7487677778484307
EBIT margin: 13.042775127355059%
Interest burden factor: 0.38479024591857824
Tax burden factor: -0.2798066595059076
ROE archetype: Low Return
DuPont ROE decomposition for DNO.OL (quarterly period ending 2024-12-31)
ROE: -9.11111111111111%
Net margin: -55.687606112054326%
Asset turnover: 0.059573176898958226
Equity multiplier (leverage): 2.746388888888889
EBIT margin: 12.959818902093945%
Interest burden factor: -4.048034934497816
ROE archetype: Low Return
DuPont ROE decomposition for DNO.OL (quarterly period ending 2025-03-31)
ROE: -0.34850353583102184%
Net margin: -1.9189765458422177%
Asset turnover: 0.05816353548900915
Equity multiplier (leverage): 3.1223869604242402
EBIT margin: 13.00639658848614%
Interest burden factor: 0.6434426229508197
Tax burden factor: -0.22929936305732487
ROE archetype: Low Return
DuPont ROE decomposition for DNO.OL (quarterly period ending 2025-06-30)
ROE: -0.5936270446375662%
Net margin: -2.8294573643410854%
Asset turnover: 0.05252621356914751
Equity multiplier (leverage): 3.994242506703949
EBIT margin: 32.67441860465116%
Interest burden factor: 0.5682087781731909
Tax burden factor: -0.1524008350730689
ROE archetype: Low Return
DuPont ROE decomposition for DNO.OL (quarterly period ending 2025-12-31)
ROE: -2.4711474161085114%
Net margin: -7.080564784053156%
Asset turnover: 0.0786454943234203
Equity multiplier (leverage): 4.43768944726493
EBIT margin: 20.390365448504983%
Interest burden factor: 1.6659877800407332
Tax burden factor: -0.2084352078239609
ROE archetype: Low Return
DuPont ROE decomposition for DNO.OL (quarterly period ending 2026-03-31)
ROE: 3.8722027650541566%
Net margin: 8.06631595727722%
Asset turnover: 0.10436814413399526
Equity multiplier (leverage): 4.599545300005672
EBIT margin: 44.63574047505181%
Interest burden factor: 0.9164285714285714
Tax burden factor: 0.19719407638347625
ROE archetype: Low Return
DuPont ROE decomposition for DOL.TO (annual period ending 2023-01-31)
ROE: 2822.467441041883%
Net margin: 15.86986152664465%
Asset turnover: 1.0483613353318162
Equity multiplier (leverage): 169.64646251319934
EBIT margin: 22.682777526099205%
Interest burden factor: 0.938927774316771
Tax burden factor: 0.7451517367696707
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DOL.TO (annual period ending 2024-01-31)
ROE: 493.80097640119465%
Net margin: 17.22174992858784%
Asset turnover: 1.1637796217355432
Equity multiplier (leverage): 24.637913003533235
EBIT margin: 24.209029360453822%
Interest burden factor: 0.9510365889717748
Tax burden factor: 0.7480018565689451
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DOL.TO (annual period ending 2025-01-31)
ROE: 146.0343872422161%
Net margin: 18.221091211878104%
Asset turnover: 1.053209774402103
Equity multiplier (leverage): 7.609670805903184
EBIT margin: 24.64895148947981%
Interest burden factor: 0.9785693455037504
Tax burden factor: 0.7554127750023273
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DOL.TO (annual period ending 2026-01-31)
ROE: 102.21211810692974%
Net margin: 18.04689078488604%
Asset turnover: 1.0675039116012017
Equity multiplier (leverage): 5.305551358816259
EBIT margin: 24.068112011515275%
Interest burden factor: 1.0102294936274676
Tax burden factor: 0.742233107941505
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DOMO (annual period ending 2023-01-31)
Net margin: -34.198188857749194%
Asset turnover: 1.2747815096895703
EBIT margin: -28.59369178182054%
ROE archetype: Standard Business
DuPont ROE decomposition for DOMO (annual period ending 2024-01-31)
Net margin: -23.69015859481048%
Asset turnover: 1.3638536393487481
EBIT margin: -16.482700030408573%
ROE archetype: Standard Business
DuPont ROE decomposition for DOMO (annual period ending 2025-01-31)
Net margin: -25.8434160558156%
Asset turnover: 1.441109090909091
EBIT margin: -18.69835101752438%
ROE archetype: Standard Business
DuPont ROE decomposition for DOMO (annual period ending 2026-01-31)
Net margin: -18.61085063210154%
Asset turnover: 1.4175422841557506
EBIT margin: -11.197182436013636%
ROE archetype: Standard Business
DuPont ROE decomposition for DOU.DE (annual period ending 2022-09-30)
Net margin: -8.530251529571721%
Asset turnover: 0.8374131845610838
EBIT margin: 4.821210061182869%
Interest burden factor: -2.0135363790186123
ROE archetype: Standard Business
DuPont ROE decomposition for DOU.DE (annual period ending 2023-09-30)
Net margin: 0.40792398446469136%
Asset turnover: 0.9535641411592015
EBIT margin: 8.857080045921983%
Interest burden factor: 0.18008825151682295
Tax burden factor: 0.2557427258805513
ROE archetype: Standard Business
DuPont ROE decomposition for DOU.DE (annual period ending 2024-09-30)
Net margin: 1.887216355875084%
Asset turnover: 1.0184134263086622
EBIT margin: 8.092563468883398%
Interest burden factor: 0.22903942254303167
Tax burden factor: 1.018181818181818
ROE archetype: Standard Business
DuPont ROE decomposition for DOU.DE (annual period ending 2025-09-30)
ROE: 21.113098721056584%
Net margin: 3.833628395952178%
Asset turnover: 1.0249053720311894
Equity multiplier (leverage): 5.373511660954608
EBIT margin: 7.564531287565843%
Interest burden factor: 0.6807281132620631
Tax burden factor: 0.7444821731748726
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DOX (annual period ending 2022-09-30)
ROE: 15.434216092114156%
Net margin: 12.006497262108459%
Asset turnover: 0.716183965524499
Equity multiplier (leverage): 1.7949140488467474
EBIT margin: 14.525693966631396%
Interest burden factor: 0.9753443532386579
Tax burden factor: 0.8474643973066258
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DOX (annual period ending 2023-09-30)
ROE: 15.236312666527294%
Net margin: 11.109083283035467%
Asset turnover: 0.7627235420347274
Equity multiplier (leverage): 1.7981855452554365
EBIT margin: 14.831377684115763%
Interest burden factor: 0.8778712937531298
Tax burden factor: 0.8532295348080727
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DOX (annual period ending 2024-09-30)
ROE: 14.047929348386786%
Net margin: 9.916525291064577%
Asset turnover: 0.781309566692255
Equity multiplier (leverage): 1.813132942047738
EBIT margin: 15.178774618685475%
Interest burden factor: 0.7780362144857943
Tax burden factor: 0.8396977689651497
ROE archetype: Standard Business
DuPont ROE decomposition for DOX (annual period ending 2025-09-30)
ROE: 16.292127657712346%
Net margin: 12.525477546116592%
Asset turnover: 0.7174617037771214
Equity multiplier (leverage): 1.8129456601476903
EBIT margin: 17.917904005658173%
Interest burden factor: 0.8535329221881721
Tax burden factor: 0.8190054843763073
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DPM.AX (quarterly period ending 2025-03-31)
ROE: 2.723441889501613%
Net margin: 23.24293949926117%
Asset turnover: 0.10217481294141999
Equity multiplier (leverage): 1.1467881854125481
EBIT margin: 38.30187239415319%
Interest burden factor: 0.6982666497618227
Tax burden factor: 0.8690599709483295
ROE archetype: Low Return
DuPont ROE decomposition for DPM.AX (quarterly period ending 2025-06-30)
ROE: 6.722701056962617%
Net margin: 44.18484934606702%
Asset turnover: 0.1330202397373931
Equity multiplier (leverage): 1.1438068545778708
EBIT margin: 49.459211634054924%
Interest burden factor: 0.9974955277280858
Tax burden factor: 0.8956023651145603
ROE archetype: Standard Business
DuPont ROE decomposition for DPM.AX (quarterly period ending 2025-09-30)
ROE: 5.167795667066984%
Net margin: 35.893916900075915%
Asset turnover: 0.12126984157353585
Equity multiplier (leverage): 1.1872212741187878
EBIT margin: 42.96051426071282%
Interest burden factor: 0.9434985463344997
Tax burden factor: 0.8855440027308541
ROE archetype: Standard Business
DuPont ROE decomposition for DPM.AX (quarterly period ending 2025-12-31)
ROE: 6.343473319000774%
Net margin: 44.64325235363217%
Asset turnover: 0.11795289674825159
Equity multiplier (leverage): 1.2046549797177426
EBIT margin: 54.584688196939%
Interest burden factor: 0.9514333983105913
Tax burden factor: 0.8596201757069802
ROE archetype: Standard Business
DuPont ROE decomposition for DPM.AX (quarterly period ending 2026-03-31)
ROE: 6.243279376791406%
Net margin: 53.45723086440437%
Asset turnover: 0.09808242033231543
Equity multiplier (leverage): 1.190735048636406
EBIT margin: 59.28039334458893%
Interest burden factor: 1.0278827078294426
Tax burden factor: 0.877307458424768
ROE archetype: Standard Business
DuPont ROE decomposition for DPRO (annual period ending 2022-12-31)
ROE: -250.47243965404567%
Net margin: -363.63115657616856%
Asset turnover: 0.5195233019592879
Equity multiplier (leverage): 1.3258482724340566
EBIT margin: -353.8105621534297%
ROE archetype: Low Return
DuPont ROE decomposition for DPRO (annual period ending 2023-12-31)
ROE: -424.52528079024114%
Net margin: -360.21936150406066%
Asset turnover: 0.5816630218154716
Equity multiplier (leverage): 2.0261194732786185
EBIT margin: -344.9526167068558%
ROE archetype: Low Return
DuPont ROE decomposition for DPRO (annual period ending 2024-12-31)
ROE: -548.1402430715241%
Net margin: -211.51282834848973%
Asset turnover: 0.6825697176805662
Equity multiplier (leverage): 3.7967146543487327
EBIT margin: -224.65130988842495%
ROE archetype: Low Return
DuPont ROE decomposition for DPRO (annual period ending 2025-12-31)
ROE: -45.4959802378664%
Net margin: -297.2525479025601%
Asset turnover: 0.13909974853892776
Equity multiplier (leverage): 1.1003252922823321
EBIT margin: -268.92417091710524%
ROE archetype: Low Return
DuPont ROE decomposition for DPT.PA (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 2.1151810139624114
ROE archetype: Standard Business
DuPont ROE decomposition for DPT.PA (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 2.126569130557939
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2025-03-31)
Net margin: 13.457146043005027%
Asset turnover: 0.5922692516426389
EBIT margin: 18.89248383174948%
Interest burden factor: 0.9161664961089031
Tax burden factor: 0.7774804916823391
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2025-06-30)
Net margin: 11.447555940562934%
Asset turnover: 0.6208573151107969
EBIT margin: 19.312942302452793%
Interest burden factor: 0.7607625214210462
Tax burden factor: 0.7791394999138193
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2025-09-30)
Net margin: 12.145810049047386%
Asset turnover: 0.6608272337875947
EBIT margin: 19.45575360881005%
Interest burden factor: 0.8029780255233725
Tax burden factor: 0.7774541152573397
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2025-12-31)
Net margin: 11.82771823355516%
Asset turnover: 0.9096002767169242
EBIT margin: 19.24297081537239%
Interest burden factor: 0.7796576904595935
Tax burden factor: 0.7883605461663324
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2026-03-31)
Net margin: 12.151201900931172%
Asset turnover: 0.6462292193621528
EBIT margin: 19.344529868919878%
Interest burden factor: 0.8115932913104229
Tax burden factor: 0.7739672944276524
ROE archetype: Standard Business
DuPont ROE decomposition for DPZ (quarterly period ending 2026-06-30)
Net margin: 11.365282265052615%
EBIT margin: 19.08463221276813%
Interest burden factor: 0.7687100793149435
Tax burden factor: 0.7747005347288406
ROE archetype: Standard Business
DuPont ROE decomposition for DR.TO (annual period ending 2022-12-31)
ROE: 10.720015345446935%
Net margin: 2.8960007160506036%
Asset turnover: 1.1237721385633856
Equity multiplier (leverage): 3.2939612178704705
EBIT margin: 12.127636020171899%
Interest burden factor: 0.33994328775637045
Tax burden factor: 0.7024510083985601
ROE archetype: Standard Business
DuPont ROE decomposition for DR.TO (annual period ending 2023-12-31)
ROE: 38.32303207654329%
Net margin: 12.957040544679248%
Asset turnover: 0.9412214708456416
Equity multiplier (leverage): 3.142405449986923
EBIT margin: 14.481588804862536%
Interest burden factor: 0.7098991377907923
Tax burden factor: 1.2603551990833572
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DR.TO (annual period ending 2024-12-31)
ROE: 76.6014495536172%
Net margin: 42.89603718994831%
Asset turnover: 0.6735191896301452
Equity multiplier (leverage): 2.6513669651622758
EBIT margin: 21.28100516888268%
Interest burden factor: 0.806778690089746
Tax burden factor: 2.4984497408345367
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DR.TO (annual period ending 2025-12-31)
ROE: 36.73608087777603%
Net margin: 17.475980264866266%
Asset turnover: 0.8410534217978456
Equity multiplier (leverage): 2.4993535532593083
EBIT margin: 18.35729405191882%
Interest burden factor: 0.8484718590595397
Tax burden factor: 1.122006668687481
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DRDB (annual period ending 2024-12-31)
Equity multiplier (leverage): 1.0014903512846096
ROE archetype: Standard Business
DuPont ROE decomposition for DRDB (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.0031554460286471
ROE archetype: Standard Business
DuPont ROE decomposition for DRREDDY.NS (annual period ending 2023-03-31)
ROE: 19.510283950456945%
Net margin: 18.328934150537457%
Asset turnover: 0.7639457642285011
Equity multiplier (leverage): 1.393361646124741
EBIT margin: 24.017504544918435%
Interest burden factor: 1.0222338876282724
Tax burden factor: 0.7465502675302732
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DRREDDY.NS (annual period ending 2024-03-31)
ROE: 21.617699261470435%
Net margin: 19.94669799830924%
Asset turnover: 0.781502271259805
Equity multiplier (leverage): 1.3867820572204876
EBIT margin: 23.394133914115002%
Interest burden factor: 1.1004777362650824
Tax burden factor: 0.7747878113260054
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DRREDDY.NS (annual period ending 2025-03-31)
ROE: 18.31988694826644%
Net margin: 17.58489870520835%
Asset turnover: 0.7311300816087379
Equity multiplier (leverage): 1.424912726826944
EBIT margin: 22.121738061959544%
Interest burden factor: 1.066237120559891
Tax burden factor: 0.7455329235257345
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for DRREDDY.NS (annual period ending 2026-03-31)
ROE: 11.390398568802784%
Net margin: 12.755519701845309%
Asset turnover: 0.5981889105150583
Equity multiplier (leverage): 1.492802677996086
EBIT margin: 14.920534749488738%
Interest burden factor: 1.093649621930052
Tax burden factor: 0.7816918109345642
ROE archetype: Standard Business
DuPont ROE decomposition for DRUG (quarterly period ending 2025-03-31)
ROE: -5.292875329135764%
Asset turnover: 0
Equity multiplier (leverage): 1.0130387230945108
ROE archetype: Low Return
DuPont ROE decomposition for DRUG (quarterly period ending 2025-06-30)
ROE: -9.74780664264301%
Asset turnover: 0
Equity multiplier (leverage): 1.0129647220898925
ROE archetype: Low Return
DuPont ROE decomposition for DRUG (quarterly period ending 2025-09-30)
ROE: -6.103624547291067%
Asset turnover: 0
Equity multiplier (leverage): 1.0227410417132743
ROE archetype: Low Return
DuPont ROE decomposition for DRUG (quarterly period ending 2025-12-31)
ROE: -8.831515724643676%
Asset turnover: 0
Equity multiplier (leverage): 1.0232068235597798
ROE archetype: Low Return
DuPont ROE decomposition for DRUG (quarterly period ending 2026-03-31)
ROE: -5.258565059415496%
Asset turnover: 0
Equity multiplier (leverage): 1.013654635139312
ROE archetype: Low Return
DuPont ROE decomposition for DSV.TO (quarterly period ending 2025-03-31)
ROE: -8.768891232693855%
Asset turnover: 0
Equity multiplier (leverage): 1.096623656699437
ROE archetype: Low Return
DuPont ROE decomposition for DSV.TO (quarterly period ending 2025-06-30)
ROE: 1.933345734182878%
Net margin: 3.8969086684036336%
Asset turnover: 0.1736218308377865
Equity multiplier (leverage): 2.8574916209702232
EBIT margin: 30.371804802478696%
Interest burden factor: 0.5682687626069416
Tax burden factor: 0.22578539371685027
ROE archetype: Low Return
DuPont ROE decomposition for DSV.TO (quarterly period ending 2025-09-30)
ROE: 7.912149269761895%
Net margin: 17.909698220382257%
Asset turnover: 0.1436991826256858
Equity multiplier (leverage): 3.074340074223905
EBIT margin: 32.35891138204177%
Interest burden factor: 0.9274368136884112
Tax burden factor: 0.5967741935483871
ROE archetype: Standard Business
DuPont ROE decomposition for DSV.TO (quarterly period ending 2025-12-31)
ROE: 11.039568553325008%
Net margin: 23.807075502658236%
Asset turnover: 0.1572551588953371
Equity multiplier (leverage): 2.9487716984029424
EBIT margin: 28.50766840965279%
Interest burden factor: 0.7719237656689689
Tax burden factor: 1.081857197302358
ROE archetype: Standard Business
DuPont ROE decomposition for DSV.TO (quarterly period ending 2026-03-31)
ROE: 12.56576434782189%
Net margin: 28.655779114845547%
Asset turnover: 0.15739760156074106
Equity multiplier (leverage): 2.7859837552737643
EBIT margin: 50.156998263371165%
Interest burden factor: 0.9189032280628127
Tax burden factor: 0.6217430026413744
ROE archetype: Standard Business
DuPont ROE decomposition for DSWL (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.2198742418566033
ROE archetype: Standard Business
DuPont ROE decomposition for DSWL (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.1981559257379748
ROE archetype: Standard Business
DuPont ROE decomposition for DSWL (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.1820188899198247
ROE archetype: Standard Business
DuPont ROE decomposition for DSY.V (quarterly period ending 2025-02-28)
ROE: -10.782405591400462%
Net margin: -29.646938286822405%
Asset turnover: 0.31461483170268423
Equity multiplier (leverage): 1.155996774850976
EBIT margin: -31.66691528324625%
ROE archetype: Low Return
DuPont ROE decomposition for DSY.V (quarterly period ending 2025-05-31)
ROE: -2.608417866584085%
Net margin: -6.374811171087592%
Asset turnover: 0.35662912835665717
Equity multiplier (leverage): 1.1473423628510582
EBIT margin: -4.550589393128346%
ROE archetype: Low Return
DuPont ROE decomposition for DSY.V (quarterly period ending 2025-08-31)
ROE: -14.51205543618772%
Net margin: -33.33767195804172%
Asset turnover: 0.36935056897161456
Equity multiplier (leverage): 1.1785686578099226
EBIT margin: -33.377593129016134%
ROE archetype: Low Return
DuPont ROE decomposition for DSY.V (quarterly period ending 2025-11-30)
ROE: 3.3839686919107335%
Net margin: 6.729094654740941%
Asset turnover: 0.4145837548506482
Equity multiplier (leverage): 1.2129905527048706
EBIT margin: 6.214831969715373%
Interest burden factor: 1.082747641051528
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for DSY.V (quarterly period ending 2026-02-28)
ROE: -25.985890017732764%
Net margin: -56.455479912950636%
Asset turnover: 0.359754983933877
Equity multiplier (leverage): 1.2794539906410887
EBIT margin: -52.14059489048548%
ROE archetype: Low Return
DuPont ROE decomposition for DSY.V (quarterly period ending 2026-05-31)
ROE: -11.642001266611128%
Net margin: -20.5296222373205%
Asset turnover: 0.4040917108484897
Equity multiplier (leverage): 1.4033524019718857
EBIT margin: -22.637082602745792%
ROE archetype: Low Return
DuPont ROE decomposition for DTL.AX (annual period ending 2022-06-30)
ROE: 49.04938651798308%
Net margin: 1.380300590078274%
Asset turnover: 2.8440238322867035
Equity multiplier (leverage): 12.49472421673664
EBIT margin: 2.007734828301681%
Interest burden factor: 1.001703848425644
Tax burden factor: 0.6863220919420316
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DTL.AX (annual period ending 2023-06-30)
ROE: 55.8543018636166%
Net margin: 1.4460889600499864%
Asset turnover: 2.946057975727072
Equity multiplier (leverage): 13.110532400665083
EBIT margin: 1.942320459249424%
Interest burden factor: 1.0703098297042444
Tax burden factor: 0.6956080700304317
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DTL.AX (annual period ending 2024-06-30)
ROE: 60.656102610704224%
Net margin: 5.3752671437400865%
Asset turnover: 0.8974891640766044
Equity multiplier (leverage): 12.57318295167524
EBIT margin: 6.6087824202664365%
Interest burden factor: 1.1656901408450704
Tax burden factor: 0.6977429800396308
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DTL.AX (annual period ending 2025-06-30)
ROE: 60.023668709801214%
Net margin: 5.652200938475991%
Asset turnover: 0.9341301206242699
Equity multiplier (leverage): 11.36835345040817
EBIT margin: 6.9867320933690955%
Interest burden factor: 1.1602403773521563
Tax burden factor: 0.6972612450990321
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DUKE.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.5587255889239666
ROE archetype: Standard Business
DuPont ROE decomposition for DUKE.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.5350040231031594
ROE archetype: Standard Business
DuPont ROE decomposition for DUKE.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.5153232099499085
ROE archetype: Standard Business
DuPont ROE decomposition for DUKE.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.5481946728991027
ROE archetype: Standard Business
DuPont ROE decomposition for DVD.OL (quarterly period ending 2024-12-31)
ROE: 82.06597731581498%
Net margin: 41.20735507246377%
Asset turnover: 0.10387745405121958
Equity multiplier (leverage): 19.171986259548387
EBIT margin: 74.3378695652174%
Interest burden factor: 0.728380779258353
Tax burden factor: 0.7610376668889131
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DVD.OL (quarterly period ending 2025-03-31)
ROE: 86.25397677846152%
Net margin: 48.48799259259259%
Asset turnover: 0.10712011404484874
Equity multiplier (leverage): 16.60633889302714
EBIT margin: 73.42524444444443%
Interest burden factor: 0.6904497877811324
Tax burden factor: 0.9564377368856316
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DVD.OL (quarterly period ending 2025-06-30)
ROE: 86.15465973159051%
Net margin: 57.876732600732595%
Asset turnover: 0.11099650481669994
Equity multiplier (leverage): 13.41113279325092
EBIT margin: 74.21217582417582%
Interest burden factor: 0.6960426899923218
Tax burden factor: 1.1204512454179516
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DVD.OL (quarterly period ending 2025-12-31)
ROE: 40.601803753527165%
Net margin: 31.439194805194802%
Asset turnover: 0.09876263752176848
Equity multiplier (leverage): 13.076190335110171
EBIT margin: 56.36291774891775%
Interest burden factor: 0.5730782742698562
Tax burden factor: 0.9733387264346668
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DVD.OL (quarterly period ending 2026-03-31)
ROE: 56.32546665918126%
Net margin: 36.70678127337434%
Asset turnover: 0.08634075247681043
Equity multiplier (leverage): 17.77226029260962
EBIT margin: 60.76881663564141%
Interest burden factor: 0.6460302424213055
Tax burden factor: 0.9350022924434446
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DWARKESH.NS (annual period ending 2023-03-31)
ROE: 14.158752301316312%
Net margin: 5.008351268526418%
Asset turnover: 1.6340460441502553
Equity multiplier (leverage): 1.7300789138598043
EBIT margin: 7.79436428514461%
Interest burden factor: 0.9355449388023519
Tax burden factor: 0.6868302713732855
ROE archetype: Standard Business
DuPont ROE decomposition for DWARKESH.NS (annual period ending 2024-03-31)
ROE: 10.615495828123517%
Net margin: 4.886057477082438%
Asset turnover: 1.2590051668466586
Equity multiplier (leverage): 1.725655897807072
EBIT margin: 8.919567327077207%
Interest burden factor: 0.9444045802828506
Tax burden factor: 0.5800383370605475
ROE archetype: Standard Business
DuPont ROE decomposition for DWARKESH.NS (annual period ending 2025-03-31)
ROE: 2.8294384287801564%
Net margin: 1.7172702234790713%
Asset turnover: 0.9324465488795244
Equity multiplier (leverage): 1.7670045274168205
EBIT margin: 4.749767345748722%
Interest burden factor: 0.8127891447358229
Tax burden factor: 0.44482420106556364
ROE archetype: Low Return
DuPont ROE decomposition for DWARKESH.NS (annual period ending 2026-03-31)
ROE: 3.5898648740829007%
Net margin: 2.199667432082647%
Asset turnover: 0.9630659956991261
Equity multiplier (leverage): 1.6945915167670598
EBIT margin: 3.576531706938504%
Interest burden factor: 0.8480598634245964
Tax burden factor: 0.7252177675766185
ROE archetype: Low Return
DuPont ROE decomposition for DXC.AX (annual period ending 2022-06-30)
ROE: 14.902852567454977%
Net margin: 149.10327655889145%
Asset turnover: 0.06347795611609831
Equity multiplier (leverage): 1.5745602487205104
EBIT margin: 75.63149538106236%
Interest burden factor: 1.9714442482942887
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for DXC.AX (annual period ending 2023-06-30)
ROE: -1.5322075712150085%
Net margin: -14.113446510374562%
Asset turnover: 0.06935985984853564
Equity multiplier (leverage): 1.5652233406269869
EBIT margin: 76.19240097008893%
Interest burden factor: -0.18523430592396112
ROE archetype: Low Return
DuPont ROE decomposition for DXC.AX (annual period ending 2024-06-30)
ROE: 0.6787668968866113%
Net margin: 5.966411572071521%
Asset turnover: 0.0736146084771885
Equity multiplier (leverage): 1.5454090062783332
EBIT margin: 74.3848834562107%
Interest burden factor: 0.08021000094170827
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for DXC.AX (annual period ending 2025-06-30)
ROE: 7.854556294969848%
Net margin: 70.36851699610393%
Asset turnover: 0.07433909233448294
Equity multiplier (leverage): 1.5015023080713614
EBIT margin: 73.04571612395895%
Interest burden factor: 0.9633489919749461
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for DXCO3.SA (annual period ending 2022-12-31)
ROE: 12.830894711522008%
Net margin: 9.013238439195678%
Asset turnover: 0.5431521699686479
Equity multiplier (leverage): 2.620924811005971
EBIT margin: 16.433221589201864%
Interest burden factor: 0.6579128514372988
Tax burden factor: 0.8336615642829507
ROE archetype: Standard Business
DuPont ROE decomposition for DXCO3.SA (annual period ending 2023-12-31)
ROE: 13.523267460164554%
Net margin: 10.987742924711338%
Asset turnover: 0.45684856560135656
Equity multiplier (leverage): 2.69402041203205
EBIT margin: 16.89478396767672%
Interest burden factor: 0.6022449697814113
Tax burden factor: 1.0798978232192609
ROE archetype: Standard Business
DuPont ROE decomposition for DXCO3.SA (annual period ending 2024-12-31)
ROE: 2.2491726518255444%
Net margin: 2.117577110469945%
Asset turnover: 0.40126831651305556
Equity multiplier (leverage): 2.6469679961405514
EBIT margin: 11.773449426551009%
Interest burden factor: 0.35531025206755634
Tax burden factor: 0.5062065642109419
ROE archetype: Low Return
DuPont ROE decomposition for DXCO3.SA (annual period ending 2025-12-31)
ROE: 0.9282347445099991%
Net margin: 0.7645398964594886%
Asset turnover: 0.4701518293683067
Equity multiplier (leverage): 2.582376355744563
EBIT margin: 7.535054999835126%
Interest burden factor: -0.14191824283884752
ROE archetype: Low Return
DuPont ROE decomposition for DY (annual period ending 2023-01-31)
ROE: 16.369747512244533%
Net margin: 3.734132045954509%
Asset turnover: 1.6463656822813233
Equity multiplier (leverage): 2.6627230922411957
EBIT margin: 5.5281895946447674%
Interest burden factor: 0.8555279544407449
Tax burden factor: 0.789537091526854
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DY (annual period ending 2024-01-31)
ROE: 22.764037431417414%
Net margin: 5.242943844367265%
Asset turnover: 1.7289663920644933
Equity multiplier (leverage): 2.5112360280772026
EBIT margin: 7.735295794063283%
Interest burden factor: 0.9040412640521621
Tax burden factor: 0.7497388689687293
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DY (annual period ending 2025-01-31)
ROE: 20.352060574961644%
Net margin: 4.964106869949771%
Asset turnover: 1.7216393531459186
Equity multiplier (leverage): 2.381360155169279
EBIT margin: 7.242343387322964%
Interest burden factor: 0.9038398289754974
Tax burden factor: 0.7583514734071932
ROE archetype: Balanced Compounder
DuPont ROE decomposition for DY (annual period ending 2026-01-31)
ROE: 18.1515722026071%
Net margin: 5.070203061281895%
Asset turnover: 1.2428442042281351
Equity multiplier (leverage): 2.8805286755386055
EBIT margin: 7.664510363669673%
Interest burden factor: 0.8654517993633944
Tax burden factor: 0.7643601766904519
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for DY6.DE (quarterly period ending 2025-03-31)
ROE: 3.4454748527719485%
Net margin: 11.433063791554357%
Asset turnover: 0.14394723228142783
Equity multiplier (leverage): 2.0935490421715293
EBIT margin: 23.62982929020665%
Interest burden factor: 0.6140684410646388
Tax burden factor: 0.7879256965944272
ROE archetype: Low Return
DuPont ROE decomposition for DY6.DE (quarterly period ending 2025-06-30)
ROE: 6.10011641443539%
Net margin: 21.405228758169933%
Asset turnover: 0.13748836612214768
Equity multiplier (leverage): 2.07277565275237
EBIT margin: 22.899159663865547%
Interest burden factor: 1.18348623853211
Tax burden factor: 0.7898363479758829
ROE archetype: Standard Business
DuPont ROE decomposition for DY6.DE (quarterly period ending 2025-09-30)
ROE: 4.523203446250245%
Net margin: 16.000923574232278%
Asset turnover: 0.1383462969765696
Equity multiplier (leverage): 2.0433065726780235
EBIT margin: 22.67374740244747%
Interest burden factor: 0.9287169042769857
Tax burden factor: 0.7598684210526315
ROE archetype: Low Return
DuPont ROE decomposition for DY6.DE (quarterly period ending 2025-12-31)
ROE: 3.640132132910163%
Net margin: 13.637466634312059%
Asset turnover: 0.1312002546959567
Equity multiplier (leverage): 2.034458190297299
EBIT margin: 20.40766804173744%
Interest burden factor: 0.8882282996432818
Tax burden factor: 0.7523427041499331
ROE archetype: Low Return
DuPont ROE decomposition for DY6.DE (quarterly period ending 2026-03-31)
ROE: 0.7752939656286342%
Net margin: 3.152088258471237%
Asset turnover: 0.11870537245486577
Equity multiplier (leverage): 2.072037730972994
EBIT margin: 8.195429472025216%
Interest burden factor: 0.532051282051282
Tax burden factor: 0.7228915662650602
ROE archetype: Low Return
DuPont ROE decomposition for DYH.DE (quarterly period ending 2025-01-31)
ROE: 7.520796399836356%
Net margin: 3.4282339777460065%
Asset turnover: 0.5569423046962904
Equity multiplier (leverage): 3.9389744988408566
EBIT margin: 4.559582271399266%
Interest burden factor: 0.9584185412406271
Tax burden factor: 0.7844950213371266
ROE archetype: Standard Business
DuPont ROE decomposition for DYH.DE (quarterly period ending 2025-04-30)
ROE: 6.996927025292946%
Net margin: 4.344544158349409%
Asset turnover: 0.41851975358477983
Equity multiplier (leverage): 3.8481072501941713
EBIT margin: 6.172943051245492%
Interest burden factor: 0.938858695652174
Tax burden factor: 0.7496382054992764
ROE archetype: Standard Business
DuPont ROE decomposition for DYH.DE (quarterly period ending 2025-07-31)
ROE: 6.158000461026773%
Net margin: 3.7086985839514495%
Asset turnover: 0.4421586165772212
Equity multiplier (leverage): 3.755260644778872
EBIT margin: 5.2239101979294755%
Interest burden factor: 0.9248291571753986
Tax burden factor: 0.7676518883415435
ROE archetype: Standard Business
DuPont ROE decomposition for DYH.DE (quarterly period ending 2025-10-31)
ROE: 4.456518223860806%
Net margin: 2.7265532251681837%
Asset turnover: 0.42887934692215
Equity multiplier (leverage): 3.811066912454319
EBIT margin: 3.7514839730906213%
Interest burden factor: 0.9061181434599156
Tax burden factor: 0.8020954598370198
ROE archetype: Low Return
DuPont ROE decomposition for DYH.DE (quarterly period ending 2026-01-31)
ROE: 6.600138950293691%
Net margin: 3.4315174202869994%
Asset turnover: 0.5097546890300549
Equity multiplier (leverage): 3.7731636455504325
EBIT margin: 4.531573244015368%
Interest burden factor: 0.9478260869565217
Tax burden factor: 0.7989296636085627
ROE archetype: Standard Business
DuPont ROE decomposition for DYH.DE (quarterly period ending 2026-04-30)
ROE: 4.797297297297297%
Net margin: 3.0696065715520966%
Asset turnover: 0.4330723404255319
Equity multiplier (leverage): 3.6087223587223587
EBIT margin: 4.460951931769053%
Interest burden factor: 0.9101321585903084
Tax burden factor: 0.7560503388189739
ROE archetype: Low Return
DuPont ROE decomposition for ECF.DE (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.13965104781432
ROE archetype: Standard Business
DuPont ROE decomposition for ECG (quarterly period ending 2025-03-31)
ROE: 7.968726572634882%
Net margin: 4.401122363010987%
Asset turnover: 0.6145545920741795
Equity multiplier (leverage): 2.9462189183375016
EBIT margin: 6.118750615067412%
Interest burden factor: 0.9190530362466656
Tax burden factor: 0.7826365324284525
ROE archetype: Standard Business
DuPont ROE decomposition for ECG (quarterly period ending 2025-06-30)
ROE: 10.843949567415823%
Net margin: 5.706686076649273%
Asset turnover: 0.652739438267828
Equity multiplier (leverage): 2.911143762415248
EBIT margin: 7.830264885786363%
Interest burden factor: 0.9599349028369675
Tax burden factor: 0.7592166891755984
ROE archetype: Standard Business
DuPont ROE decomposition for ECG (quarterly period ending 2025-09-30)
ROE: 10.478962347867268%
Net margin: 5.751046709275237%
Asset turnover: 0.6381242808232744
Equity multiplier (leverage): 2.8553944760932635
EBIT margin: 7.305869243098987%
Interest burden factor: 0.9954822398143159
Tax burden factor: 0.7907541566047687
ROE archetype: Standard Business
DuPont ROE decomposition for ECG (quarterly period ending 2025-12-31)
ROE: 9.191063993934476%
Net margin: 5.423436805550786%
Asset turnover: 0.6080555006208861
Equity multiplier (leverage): 2.78707069128347
EBIT margin: 6.757760416308967%
Interest burden factor: 1.0060977380295595
Tax burden factor: 0.7976853588848163
ROE archetype: Standard Business
DuPont ROE decomposition for ECG (quarterly period ending 2026-03-31)
ROE: 8.857485255497956%
Net margin: 5.609535325085827%
Asset turnover: 0.5813467886563262
Equity multiplier (leverage): 2.716115744530902
EBIT margin: 7.472582862232791%
Interest burden factor: 0.9775500746614489
Tax burden factor: 0.7679220437187253
ROE archetype: Standard Business
DuPont ROE decomposition for ECO (quarterly period ending 2025-03-31)
ROE: 3.0496668043930355%
Net margin: 15.66600229286817%
Asset turnover: 0.07494879285808104
Equity multiplier (leverage): 2.5973445479672104
EBIT margin: 27.79877319425402%
Interest burden factor: 0.5635501316333742
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for ECO (quarterly period ending 2025-06-30)
ROE: 6.649509558302958%
Net margin: 28.619190235223147%
Asset turnover: 0.09072105096719635
Equity multiplier (leverage): 2.561086226156943
EBIT margin: 39.313760226043726%
Interest burden factor: 0.7279687842289918
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for ECO (quarterly period ending 2025-09-30)
ROE: 5.605448680485452%
Net margin: 26.54522063199475%
Asset turnover: 0.08427249742669198
Equity multiplier (leverage): 2.505752526905486
EBIT margin: 38.33136436137054%
Interest burden factor: 0.6925195873994614
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for ECO (quarterly period ending 2025-12-31)
ROE: 11.857172912242097%
Net margin: 46.87213447513747%
Asset turnover: 0.11187474646577698
Equity multiplier (leverage): 2.2611759524443635
EBIT margin: 54.06893011126586%
Interest burden factor: 0.86689591191617
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for ECO (quarterly period ending 2026-03-31)
ROE: 13.464443799879389%
Net margin: 51.90121041095779%
Asset turnover: 0.12718113812056445
Equity multiplier (leverage): 2.0398029921403085
EBIT margin: 57.62485339524782%
Interest burden factor: 0.9006740556018136
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for ECO.L (annual period ending 2022-03-31)
ROE: -16.302853211385298%
Net margin: -184401.68728908888%
Asset turnover: 7.752549773506076e-05
Equity multiplier (leverage): 1.1403920064424538
EBIT margin: -110718.64454443194%
ROE archetype: Low Return
DuPont ROE decomposition for ECO.L (annual period ending 2023-03-31)
ROE: -77.69978992692182%
Net margin: -54910.92818194108%
Asset turnover: 0.0012661387303134336
Equity multiplier (leverage): 1.1175829462221774
EBIT margin: -57627.62914782713%
ROE archetype: Low Return
DuPont ROE decomposition for ECO.L (annual period ending 2024-03-31)
ROE: -52.405374940890894%
Asset turnover: 0
Equity multiplier (leverage): 1.0769865362193518
ROE archetype: Low Return
DuPont ROE decomposition for ECO.L (annual period ending 2025-03-31)
ROE: -8.729316583636258%
Asset turnover: 0
Equity multiplier (leverage): 1.04787300072626
ROE archetype: Low Return
DuPont ROE decomposition for ECO.L (annual period ending 2026-03-31)
ROE: -39.9475801472247%
Asset turnover: 0
Equity multiplier (leverage): 1.3735498567680557
ROE archetype: Low Return
DuPont ROE decomposition for ECOR (annual period ending 2022-12-31)
ROE: -129.7085333021187%
Net margin: -257.9376163873371%
Asset turnover: 0.347067377605429
Equity multiplier (leverage): 1.4489055366967107
EBIT margin: -266.2243947858473%
ROE archetype: Low Return